NICE recommends more people have access to COVID-19 antiviral

More people should be eligible to receive the COVID-19 antiviral nirmatrelvir plus ritonavir (Paxlovid), according to new draft guidance from NICE.
Source: GP Online News - Category: Primary Care Tags: Clinical News Source Type: news